Markus Haake
12Patents
1h-index
8Co-inventors
39Inventor score
Filing activity: Nov 29, 2012 → Sep 25, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11262360B2 | GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers | Physics | 1 | Active |
| US11464856B2 | Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers | Physics | 1 | Active |
| US10682404B2 | Targets of Acinetobacter baumannii | Human Necessities | 0 | Active |
| US9597387B2 | Targets of Acinetobacter baumannii | Human Necessities | 0 | Active |
| US10111942B2 | Targets of Acinetobacter baumannii | Human Necessities | 0 | Active |
| US10603372B2 | Targets of Acinetobacter baumannii | Human Necessities | 0 | Active |
| US10463727B2 | Targets of acinetobacter baumannii | Human Necessities | 0 | Active |
| US10420828B2 | Targets of acinetobacter baumannii | Human Necessities | 0 | Active |
| US10105432B2 | Targets of acinetobacter baumannii | Human Necessities | 0 | Active |
| US10098942B2 | Targets of Acinetobacter baumannii | Human Necessities | 0 | Active |
| US10398767B2 | Targets of Acinetobacter Baumannii | Human Necessities | 0 | Active |
| US10603373B2 | Targets of Acinetobacter baumannii | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.